Enalapril and hydrochlorothiazide Sandoz GmbH: detailed information

PACKAGE LEAFLET: INFORMATION FOR THE USER

ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH 20 mg/12.5 mg tablets

Generic medicine
Read this leaflet carefully before taking this medicine

Keep this leaflet. You may need to read it again.
If you have any questions, ask your doctor or pharmacist.
This medicine has been prescribed for you personally. Never give it to others. It may be harmful to other people, even if their symptoms are the same as yours.
If any of the side effects worsens, or if you notice any side effects not listed in this leaflet, inform your doctor or pharmacist.

Contents of this leaflet:

What ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH is and what it is used for
Before you take ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH
How to take ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH
Possible side effects
How to store ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH
Further information

1. WHAT ENALAPRIL HYDROCHLOROTHIAZIDE SANDOZ GMBH IS AND WHAT IT IS USED FOR

Enalapril, which belongs to a group of medicines called angiotensin-converting enzyme (ACE) inhibitors, lowers blood pressure by widening blood vessels.
Hydrochlorothiazide, which belongs to a group of medicines called diuretics, lowers blood pressure by increasing diuresis (urine elimination).
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH tablets contain a fixed combination of enalapril and hydrochlorothiazide and are used to treat high blood pressure (hypertension) when treatment with enalapril alone has proven insufficient.
Your doctor may also prescribe ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH tablets instead of separate tablets containing the same doses of enalapril and hydrochlorothiazide.
This fixed-dose combination is not suitable for initiating therapy.

2. BEFORE TAKING ENALAPRIL HYDROCHLOROTHIAZIDE SANDOZ GMBH

DO NOT take ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH

if you are allergic (hypersensitive) to enalapril maleate, hydrochlorothiazide, or any of the excipients of this medicine;
if you are allergic (hypersensitive) to sulfonamide derivatives (mainly antibiotics such as sulfamethoxazole);
if you have previously experienced swelling of the extremities, face, lips, throat, mouth, or tongue (angioedema) while being treated with other medicines belonging to a class of drugs called ACE inhibitors (angiotensin-converting enzyme inhibitors);
if you have previously experienced, under any circumstances, swelling of the extremities, face, lips, throat, mouth, or tongue (angioedema);
if one of your blood relatives has previously experienced swelling of the extremities, face, lips, throat, mouth, or tongue (angioedema);
if you suffer from severe kidney problems;
if you are unable to urinate;
if you suffer from severe liver problems or a neurological disorder due to severe liver problems (hepatic encephalopathy);
if you are more than three months pregnant (it is better to avoid Enalapril Hydrochlorothiazide Sandoz GmbH even in the early stages of pregnancy – see section "Pregnancy");

Take special care with ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH
Before starting treatment with this medicine, inform your doctor in the following cases:

if you suffer from narrowing of the arteries (atherosclerosis), cerebrovascular disorders such as stroke or transient ischemic attack (TIA, a "mini-stroke");
if you suffer from a disease characterized by reduced blood supply to the heart muscle, usually due to coronary artery disease (ischemic heart disease);
if you suffer from heart failure;
if you have low blood pressure, follow a low-salt diet, or are taking diuretics;
if you have abnormal levels of water and electrolytes in the body (water/electrolyte imbalance), characterized especially by nausea, abdominal cramps and/or vomiting, headache, edema (swelling), muscle weakness and/or tremor;
if you suffer from a heart muscle disease (hypertrophic cardiomyopathy), narrowing of the aorta (the main artery carrying blood from the heart, aortic stenosis), or blockage of the artery supplying the only functioning kidney; if you have had a kidney transplant; or if you have other forms of cardiac disorder known as outflow obstruction;
if you are scheduled to undergo LDL apheresis (removal of cholesterol from the blood using special equipment);
if you are scheduled to undergo desensitization therapy for insect venom, such as wasp or bee stings;
if you suffer from diabetes;
if you suffer from gout, have high levels of uric acid in the blood, or are being treated with allopurinol;
if you are about to receive anesthesia;
if you have recently experienced prolonged and severe vomiting and/or a severe form of diarrhea;
if you are about to undergo parathyroid function testing;
if you suffer from or have suffered from liver or kidney problems, narrowing of the renal arteries (renal artery stenosis), have only one functioning kidney, or are undergoing hemodialysis;
if you suffer from collagen vascular diseases such as systemic lupus erythematosus (SLE) or scleroderma, which may be associated with skin rashes, joint pain, and fever;
if you are taking, among others, a medicine capable of suppressing immune responses (immunosuppressant) or procainamide, used to treat heart rhythm disorders;
if you have previously had skin cancer or develop an unexpected skin lesion during treatment. Treatment with hydrochlorothiazide, particularly long-term use at high doses, may increase the risk of certain types of non-melanoma skin cancer and lip cancer. Protect your skin from exposure to sunlight and UV radiation while taking ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH;
if you have allergies or asthma;
if you are taking lithium, used to treat certain psychiatric conditions.

If you think you are (or might become) pregnant, inform your doctor. ENALAPRIL
HYDROCHLOROTHIAZIDE Sandoz GmbH is not recommended during early pregnancy and must not
be used after the first trimester, as it may seriously harm the unborn child (see
section “Pregnancy and breastfeeding”). Breastfeeding is not recommended during treatment with
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH.
Generally, ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH is not recommended in the following
cases, so consult your doctor before taking this medicine:

if you have recently undergone a kidney transplant;
if you have high potassium levels in the blood, potassium levels should be monitored during treatment. Risk factors for elevated potassium levels include reduced kidney function, advanced age (>70 years), dehydration, acute heart failure, acidification of the blood (metabolic acidosis), diabetes (diabetes mellitus), concomitant use of diuretics, potassium supplements or potassium-containing salt substitutes, or use of medicines that increase blood potassium levels. A decrease in blood potassium levels may also occur, characterized by high blood pressure, heart rhythm disturbances, etc. (e.g., caused by drug interactions, excessive urine loss, etc.). Also refer to the section “Taking ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH with other medicines” below.

If you are an athlete and are required to undergo anti-doping testing, consult your doctor, as ENALAPRIL
HYDROCHLOROTHIAZIDE Sandoz GmbH contains an active ingredient that may lead to positive test results.
Elderly (>70 years) or malnourished patients should exercise particular caution when using
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH.
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH may be less effective in Black patients.
Use of this medicine in children is not recommended.
If, during treatment with ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH, you develop any of
the following symptoms, inform your doctor immediately:

you experience dizziness after taking the first dose. A few people react to the first dose or an increase in dosage with symptoms such as dizziness, weakness, fainting, and nausea;
you develop sudden swelling of the lips, face, and neck, which may also affect hands and feet, or experience shortness of breath or hoarseness: these are symptoms of a condition called angioedema, which may occur at any stage of treatment. ACE inhibitors cause a higher incidence of angioedema in Black patients compared to non-Black patients;
you develop a high body temperature, sore throat, or mouth ulcers (these may be symptoms of an infection caused by a decrease in white blood cells in the blood);
you develop yellowing of the skin and whites of the eyes (jaundice), which could be a sign of liver disorder;
you develop a persistent dry cough. Cough has been reported following the use of ACE inhibitors, but it could also be a symptom of another upper respiratory tract disease;
sudden onset of myopia;
if you experience decreased vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or increased intraocular pressure and may occur from a few hours to weeks after taking Enalapril Hydrochlorothiazide Sandoz. This may lead to permanent vision loss if not treated. If you have previously had an allergy to penicillin or sulfonamide, you may be at higher risk of developing this condition.

Taking ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH with other medicines
You must not take ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH together with the following
medicines:

potassium supplements or potassium-containing salt substitutes;
diuretics used to treat hypertension, including potassium-sparing diuretics such as spironolactone, triamterene, or amiloride;
other medicines used to treat high blood pressure;
anesthetics and medicines used for mental disorders or depression, medicines used to treat psychosis, tricyclic antidepressants, or sedatives;
lithium (a medicine used to treat psychiatric disorders);
painkillers and anti-inflammatory medicines, such as acetylsalicylic acid or indomethacin;
gold salts (sodium aurothiomalate), an injectable medicine used to treat rheumatoid arthritis;
medicines such as ephedrine, used in some cough and cold remedies, or noradrenaline and adrenaline, used to treat low blood pressure, shock, heart failure, asthma, or allergies;
medicines that lower blood sugar levels, such as insulin or oral antidiabetics;
cholestyramine and colestipol, active ingredients used to lower blood lipid levels;
corticosteroids, hormone-like anti-inflammatory substances;
corticotropin (ACTH), used to assess proper adrenal gland function;
muscle relaxants (e.g., tubocurarine chloride), medicines used to relax muscles during surgical procedures;
allopurinol, probenecid, sulfinpyrazone, medicines used to treat gout;
medicines such as atropine or biperiden, used to treat various disorders such as gastrointestinal cramps, bladder spasms, asthma, motion sickness, and muscle spasms, and as adjuncts in anesthesia;
cancer-treating medicines such as cyclophosphamide or methotrexate;
medicines that suppress the immune system, medicines used to prevent rejection after organ or bone marrow transplantation;
cyclosporine, a medicine used to prevent rejection after organ or bone marrow transplantation;
cardiac glycosides (e.g., digoxin), medicines used to strengthen the heart;
medicines that, as a side effect, may cause abnormalities in cardiac conduction, such as medicines used for heart rhythm disorders, some medicines used for psychosis, and other medicines such as those used to treat bacterial infections;
calcium salts and vitamin D, high calcium levels in the blood (may cause gastrointestinal disturbances, excessive thirst, excessive urination, fatigue, weakness, and weight loss);
carbamazepine, a medicine mainly used to treat epilepsy and bipolar disorder;
amphotericin B, a medicine used to treat fungal infections;
laxatives, medicines used to facilitate defecation;
iodinated contrast agents, which enhance visibility of blood vessels and organs during radiographic procedures;
barbiturates, which act as central nervous system depressants causing sedation;
opioid analgesics, potent painkillers without anti-inflammatory effect;
carbenoxolone, a medicine used to treat intestinal tract inflammation;
salicylates, medicines used to treat pain and/or inflammatory diseases.

If you are taking or have recently taken any other medicines, including those without a prescription and herbal or natural products, inform your doctor or pharmacist.
Taking ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH with food and drinks
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH can be taken with or without food.
Consumption of alcohol together with this medicine may enhance the blood pressure-lowering effect (and may therefore cause, among other effects, dizziness upon standing).
Pregnancy and breastfeeding
Ask your doctor or pharmacist for advice before taking any medicine.
Pregnancy
If you think you are (or might become) pregnant, inform your doctor, who will usually advise you to stop treatment with ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH before becoming pregnant or as soon as pregnancy is diagnosed, and to take another medicine instead. ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH is not recommended during early pregnancy and must not be used after the first trimester, as it may seriously harm the unborn child.
Breastfeeding
Inform your doctor if you are breastfeeding or plan to start breastfeeding. ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH is not recommended for breastfeeding mothers.
Driving and using machines
Patients treated with ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH have reported dizziness and fatigue: if you experience any of these symptoms, refrain from driving or operating machinery (also see section 4, “Possible side effects”).
Important information about some excipients of ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH
Patients with lactose intolerance should be informed that ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH tablets contain a small amount of lactose. If your doctor has diagnosed you with an intolerance to certain sugars, consult him before taking this medicine.

3. HOW TO TAKE ENALAPRIL IDROCLOROTIAZIDE SANDOZ GMBH

Always take ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH exactly as prescribed by your doctor. If you have any doubts, consult your doctor or pharmacist.
Adults
The usual dose is one tablet once daily.
Elderly
Your doctor may carefully adjust the dose of enalapril and hydrochlorothiazide.
Renal impairment
Your doctor will carefully adjust the dose of enalapril and hydrochlorothiazide.
Method of administration
The tablets should be swallowed with a glass of water.
ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH may be taken with or without food.
The break line is only intended to facilitate tablet splitting to aid swallowing and is not for dividing the tablet into two equal halves.
If you take more ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH than you should
If you (or someone else) have taken many tablets of ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH all at once, or if you suspect that a child has swallowed one or more tablets, seek immediate medical help. An overdose may cause low blood pressure, excessive increase or decrease in heart rate, palpitations (the sensation that the heartbeat is too fast or irregular), shock, rapid breathing, cough, nausea and vomiting, cramps, dizziness, drowsiness and confusion or anxiety, excessive urination, or inability to urinate. Show the hospital staff or doctor this patient information leaflet, any remaining tablets, and the medicine packaging so they can determine which and how many tablets have been taken.
If you forget to take ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH
Do not take a double dose of ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH to make up for a missed tablet; simply take the next dose as scheduled.
If you have any further questions about the use of this medicine, consult your doctor or pharmacist.
If you stop taking ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH
Treatment for high blood pressure is long-term, and stopping treatment should be discussed with your doctor. Stopping or interrupting treatment may cause an increase in blood pressure.
If you have any further questions about using this medicine, consult your doctor or pharmacist.

4. POSSIBLE ADVERSE EFFECTS

Like all medicines, ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH can cause adverse effects, although not everyone experiences them.
If you experience any of the following adverse effects, stop taking ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH immediately and contact your doctor or go to the nearest hospital emergency department:

a severe allergic reaction called angioedema (skin rash, itching, swelling of the extremities, face, lips, mouth or throat, which may cause difficulty in swallowing or breathing). This is a serious and common adverse effect (affecting more than 1 in 100 and less than 1 in 10 patients). Immediate medical attention or hospitalization may be required;
jaundice (yellowing of the skin and whites of the eyes). This is a potentially serious but rare adverse effect (affecting more than 1 in 10,000 and less than 1 in 1,000 patients), indicating liver inflammation. Immediate medical attention or hospitalization may be required.
Sudden onset of myopia. The frequency of this adverse effect is unknown (cannot be estimated based on available data).
Decreased vision or eye pain due to increased pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma). The frequency of this adverse effect is unknown (cannot be estimated based on available data).

ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH commonly causes low blood pressure, which may be associated with a sensation of dizziness or weakness. In some patients, this symptom may occur with the first dose or when the dose is increased. If you experience these symptoms, contact your doctor immediately.
ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH rarely causes a reduction in the number of white blood cells in the blood, which may reduce your resistance to infections. If you develop an infection with symptoms such as fever and severe deterioration in general condition, or fever with signs of local infection such as sore throat/pharyngitis/mouth irritation, or urinary symptoms, contact your doctor immediately. A blood test will be performed to check for possible reduction in white blood cells (agranulocytosis). It is important that you inform your doctor that you are taking this medicine.
Dry cough has been very commonly reported (in more than 1 in 10 patients) following the use of ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH and other ACE inhibitors. This cough may persist for a long time and may also be a symptom of another disorder of the upper respiratory tract. If you develop this symptom, contact your doctor.

The following adverse effects have also been reported:

Very common (affects more than 1 in 10 people)

blurred vision
dizziness
nausea
weakness

Common (affects more than 1 in 100 but less than 1 in 10 people)

low potassium levels in the blood, which may cause muscle weakness, cramps, or irregular heartbeat
high levels of fat or uric acid in the blood
headache, depression
fainting, low blood pressure associated with changes in posture (e.g. a sensation of dizziness or weakness when rising from a lying position), chest pain, changes in heart rhythm, excessively rapid heartbeat (tachycardia)
shortness of breath
diarrhea, abdominal pain
changes in taste
skin rash
fatigue
elevated potassium levels in the blood, which may cause heart rhythm abnormalities; increased levels of creatinine in the blood
muscle cramps

Uncommon (affects more than 1 in 1,000 but less than 1 in 100 people)

reduction in the number of red blood cells in the blood, which may cause pale skin, weakness, or difficulty breathing (anemia)
hypoglycemia (low blood sugar levels - see “Take special care with ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH especially in the following cases” in section 2)
low magnesium levels in the blood
uric acid crystals in the joints (gout)
confusion, drowsiness, insomnia, nervousness, tingling or numbness sensations, dizziness, decreased sexual desire
palpitations (awareness of a fast, strong or irregular heartbeat)
heart attack or stroke (“mini-stroke”) (mainly in patients suffering from low blood pressure)
runny nose, sore throat, hoarseness, breathing difficulties, dyspnea
intestinal obstruction, inflammation of the pancreas causing severe abdominal and back pain (pancreatitis), vomiting, indigestion, constipation, loss of appetite, gastric irritation, dry mouth, peptic ulcer, flatulence
sweating, itching, hives, hair loss
joint pain
kidney problems, presence of protein in the urine
impotence
hot flushes, ringing in the ears
malaise, fever
low sodium levels in the blood, which may cause fatigue and confusion, muscle spasms, seizures or coma, and also dehydration and low blood pressure, which in turn may cause dizziness upon standing; increased levels of urea in the blood.

Rare (affects more than 1 in 10,000 but less than 1 in 1,000 people)

reduction in the number of white blood cells, increasing susceptibility to infections; reduction in the number of other blood cells; changes in blood composition; poor bone marrow production; lymph node disease; autoimmune disease, in which the body attacks itself
unusual dreams, sleep disturbances
paralysis
Raynaud's syndrome, a blood vessel disorder that may cause tingling in fingers and toes, which turn pale, then bluish, then red
lung disorders, including pneumonia, inflammation of the nasal lining causing nasal discharge (rhinitis)
mouth ulcers, inflammation of the tongue
liver disorders, inflammation of the gallbladder
skin rash, appearance of severe blisters, skin redness, Stevens-Johnson syndrome (blisters on the skin, in the mouth, eyes and genitals), skin that appears burned and peels off, photosensitivity, skin conditions with scaly red patches on the nose and cheeks (lupus erythematosus), pemphigus (a disorder causing blisters and lesions usually starting in the mouth, hives, hair loss and itching). Sometimes, skin problems may be accompanied by fever, severe inflammation, blood vessel inflammation, muscle and/or joint pain, changes in blood composition, and increased erythrocyte sedimentation rate (a blood test used to detect inflammation)
reduced urine output
kidney inflammation (interstitial nephritis)
breast enlargement in men
increased levels of liver enzymes and waste substances produced by the liver
increased blood sugar levels

Very rare (affects less than 1 in 10,000 people)

intestinal swelling
high calcium levels in the blood (see “Take special care with ENALAPRIL IDROCLOROTIAZIDE Sandoz GmbH” in section 2)

Not known (cannot be estimated from available data)

inappropriate secretion of antidiuretic hormone (known as SIADH), causing general symptoms such as confusion, nausea, mood changes, seizures, and loss of consciousness
skin and lip cancer (non-melanoma skin cancer)

Additional adverse effects:

inflammation of a salivary gland
glucose excretion in urine (glucosuria)
decreased appetite, sensation of dizziness
predominance of yellow vision due to yellowing of the eye (xanthopsia)

If any of the adverse effects worsen, or if you notice any adverse effect not listed in this leaflet, inform your doctor or pharmacist.

5. HOW TO STORE ENALAPRIL HYDROCHLOROTHIAZIDE SANDOZ GMBH

Keep ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH out of the reach and sight of children.
Do not store above 30°C. Store in the original packaging.
Do not use ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH after the expiry date stated on the outer packaging.
Do not use ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH after the expiry date (EXP) shown on the label. The expiry date refers to the last day of the month.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. OTHER INFORMATION

What ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH contains

The active substances are enalapril maleate and hydrochlorothiazide.
Each tablet contains 20 mg of enalapril maleate and 12.5 mg of hydrochlorothiazide.
The other ingredients are: sodium hydrogen carbonate, maize starch, lactose monohydrate, calcium hydrogen phosphate dihydrate, talc, and magnesium stearate.

What ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH looks like and contents of the pack
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH 20 mg/12.5 mg tablets are white, oval, biconvex tablets, with a break line on one side and the imprint "E H" on the other.
ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH 20 mg/12.5 mg is available in packs containing 10, 14, 20, 28, 30, 49, 50, 50x1, 60, 98, 100 and 120 tablets.
Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Sandoz GmbH – Biochemiestrasse, 10 – 6250 Kundl (Austria)
Italian Representative: Sandoz Spa – Largo U. Boccioni, 1 – 21040 Origgio (VA), Italy
Manufacturer responsible for batch release
SALUTAS Pharma GmbH - Otto-von-Guericke-Allee, 1 - 39179 Barleben (Germany)

This medicinal product has been authorised in EEA Member States under the following names:
Netherlands: Enalaprilmaleaat/ Hydrochloorthiazide Sandoz 20/12.5 mg, tabletten
Belgium: Co- Enalapril Sandoz 20/12.5 mg tabletten
Denmark: Corodil comp
Finland: LINATIL-HEXAL COMP 20 mg/12.5 mg tabletti
Germany: EnaHEXAL comp 20mg/12.5mg Tabletten
Italy: ENALAPRIL HYDROCHLOROTHIAZIDE Sandoz GmbH 20 mg/12.5 mg tablets
Norway: Enalapril/hydrochlorthiazid HEXAL
Portugal: Enalapril + Hidroclorotiazida Sandoz 20 mg + 12.5 mg Comprimidos
United Kingdom: Enalapril + HCT 20mg/12.5mg Tablets
Spain: ENALAPRIL-HIDROCLOROTIAZIDA BEXAL 20/12.5 mg comprimidos EFG
Sweden: Linatil comp

This summary of product characteristics was last approved on